Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
2(17%)
Results Posted
50%(3 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_4
4
33%
Ph phase_1
1
8%
Ph not_applicable
5
42%
Ph phase_2
2
17%

Phase Distribution

1

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 4Post-market surveillance
4(33.3%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(6)
Terminated(3)
Other(1)

Detailed Status

Completed6
Terminated2
unknown1
Withdrawn1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 22 (16.7%)
Phase 44 (33.3%)
N/A5 (41.7%)

Trials by Status

terminated217%
unknown18%
withdrawn18%
completed650%
recruiting18%
active_not_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DEVICE
Total Trials
12